These medications are supported by extensive randomized controlled trial data and are recommended by the American Diabetes Association (ADA) as preferred agents for many patients with type 2 diabetes, particularly those with established cardiovascular disease or chronic kidney disease
A multi-institutional study in Taiwan by Lin and colleagues found that GLP-1RA users were more likely than sodium-glucose cotransporter 2 inhibitors (SGLT-2I) users to develop PDR or require interventions for DR complications
Maintain Healthier Blood Sugar Levels For individuals grappling with both excess weight and type 2 diabetes, semaglutide presents a dual advantage as it also enhances blood sugar control
Elevated -glucuronidase in the gut reactivates estrogen hormones that should be excreted from the body
However, the needles are extremely thin, and the process is straightforward
First isolated in the 1990s, it earned the name Body Protective Compound-157 for its ability to accelerate healing in the stomach and intestine